Current status of diagnosis and treatment of progressive hemorrhagic injury after traumatic brain injury

doi:10.3877/cma.j.issn.2095-9141.2023.03.009

Abstract

Abstract:

Traumatic brain injury (TBI) has a high morbidity and mortality, which is prone to various complications, leading to a poor prognosis of patients. Progressive hemorrhagic injury (PHI) is one of the most serious complications after TBI, and can significantly increase patient mortality. At present, the definition, occurrence mechanism and related markers of PHI are not unified. This paper mainly reviews the current research progress of PHI after TBI combined with relevant literature, in order to provide some reference for clinical work.

Key words: Traumatic brain injury, Progressive hemorrhagic injury, Diagnosis

Jiawei He, Liang Zhang, Qi Yang, Zhanxiang Wang. Current status of diagnosis and treatment of progressive hemorrhagic injury after traumatic brain injury[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(03): 175-179.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsjcswkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9141.2023.03.009

https://zhsjcswkdzzz.cma-cmc.com.cn/EN/Y2023/V09/I03/175

References 53

[1]	Jochems D, van Wessem KJP, Houwert RM, et al. Outcome in patients with isolated moderate to severe traumatic brain injury[J]. Crit Care Res Pract, 2018, 2018: 3769418. DOI: 10.1155/2018/3769418.
[2]	Alali AS, Burton K, Fowler RA, et al. Economic evaluations in the diagnosis and management of traumatic brain injury: a systematic review and analysis of quality[J]. Value Health, 2015, 18(5): 721-734. DOI: 10.1016/j.jval.2015.04.012.
[3]	Taylor CA, Bell JM, Breiding MJ, et al. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths - united states, 2007 and 2013[J]. MMWR Surveill Summ, 2017, 66(9): 1-16. DOI: 10.15585/mmwr.ss6609a1.
[4]	Folkerson LE, Sloan D, Cotton BA, et al. Predicting progressive hemorrhagic injury from isolated traumatic brain injury and coagulation[J]. Surgery, 2015, 158(3): 655-661. DOI: 10.1016/j.surg.2015.02.029.
[5]	Cepeda S, Gómez PA, Castaño-Leon AM, et al. Traumatic intracerebral hemorrhage: risk factors associated with progression[J]. J Neurotrauma, 2015, 32(16): 1246-1253. DOI: 10.1089/neu.2014.3808.
[6]	Oertel M, Kelly DF, McArthur D, et al. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury[J]. J Neurosurg, 2002, 96(1): 109-116. DOI: 10.3171/jns.2002.96.1.0109.
[7]	Stein SC, Young GS, Talucci RC, et al. Delayed brain injury after head trauma: significance of coagulopathy[J]. Neurosurgery, 1992, 30(2): 160-165. DOI: 10.1227/00006123-199202000-00002.
[8]	White CL, Griffith S, Caron JL. Early progression of traumatic cerebral contusions: characterization and risk factors[J]. J Trauma, 2009, 67(3): 508-514; discussion 514-515. DOI: 10.1097/TA.0b013e3181b2519f.
[9]	Webb AJ, Brown CS, Naylor RM, et al. Thromboelastography is a marker for clinically significant progressive hemorrhagic injury in severe traumatic brain injury[J]. Neurocrit Care, 2021, 35(3): 738-746. DOI: 10.1007/s12028-021-01217-0.
[10]	Vedantam A, Yamal JM, Rubin ML, et al. Progressive hemorrhagic injury after severe traumatic brain injury: effect of hemoglobin transfusion thresholds[J]. J Neurosurg, 2016, 125(5): 1229-1234. DOI: 10.3171/2015.11.JNS151515.
[11]	Yuan Q, Sun YR, Wu X, et al. Coagulopathy in traumatic brain injury and its correlation with progressive hemorrhagic injury: a systematic review and meta-analysis[J]. J Neurotrauma, 2016, 33(14): 1279-1291. DOI: 10.1089/neu.2015.4205.
[12]	van Gent JAN, van Essen TA, Bos MHA, et al. Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis[J]. Acta Neurochir (Wien), 2020, 162(2): 329-336. DOI: 10.1007/s00701-019-04111-z.
[13]	Tian Y, Salsbery B, Wang M, et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury[J]. Blood, 2015, 125(13): 2151-2159. DOI: 10.1182/blood-2014-09-598805.
[14]	Liu J, Tian HL. Relationship between trauma-induced coagulopathy and progressive hemorrhagic injury in patients with traumatic brain injury[J]. Chin J Traumatol, 2016, 19(3): 172-175. DOI: 10.1016/j.cjtee.2016.01.011.
[15]	Díaz-Romero R, Avendaño P, Coloma G. Life-threatening paradoxical brain herniation rapidly reversed by emergency cranioplasty repair: a case report[J]. Acta Neurochir (Wien), 2015, 157(11): 2031-2032. DOI: 10.1007/s00701-015-2569-3.
[16]	Wan X, Fan T, Wang S, et al. Progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage: characteristics, risk factors and impact on management[J]. Acta Neurochir (Wien), 2017, 159(2): 227-235. DOI: 10.1007/s00701-016-3043-6.
[17]	Carnevale JA, Segar DJ, Powers AY, et al. Blossoming contusions: identifying factors contributing to the expansion of traumatic intracerebral hemorrhage[J]. J Neurosurg, 2018, 129(5): 1305-1316. DOI: 10.3171/2017.7.JNS17988.
[18]	Rehman L, Afzal A, Aziz HF, et al. Radiological parameters to predict hemorrhagic progression of traumatic contusional brain injury[J]. J Neurosci Rural Pract, 2019, 10(2): 212-217. DOI: 10.4103/jnrp.jnrp_335_18.
[19]	Allison RZ, Nakagawa K, Hayashi M, et al. Derivation of a predictive score for hemorrhagic progression of cerebral contusions in moderate and severe traumatic brain injury[J]. Neurocrit Care, 2017, 26(1): 80-86. DOI: 10.1007/s12028-016-0303-5.
[20]	Di G, Liu H, Jiang X, et al. Clinical predictors of progressive hemorrhagic injury in children with mild traumatic brain injury[J]. Front Neurol, 2017, 8: 560. DOI: 10.3389/fneur.2017.00560.
[21]	Kim WH, Lim DJ, Kim SH, et al. Is routine repeated head CT necessary for all pediatric traumatic brain injury?[J]. J Korean Neurosurg Soc, 2015, 58(2): 125-130. DOI: 10.3340/jkns.2015.58.2.125.
[22]	Picetti E, Rossi S, Abu-Zidan FM, et al. WSES consensus conference guidelines: monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours[J]. World J Emerg Surg, 2019, 14: 53. DOI: 10.1186/s13017-019-0270-1.
[23]	Martin G, Shah D, Elson N, et al. Relationship of coagulopathy and platelet dysfunction to transfusion needs after traumatic brain injury[J]. Neurocrit Care, 2018, 28(3): 330-337. DOI: 10.1007/s12028-017-0485-5.
[24]	Gratz J, Güting H, Thorn S, et al. Protocolised thromboelastometric-guided haemostatic management in patients with traumatic brain injury: a pilot study[J]. Anaesthesia, 2019, 74(7): 883-890. DOI: 10.1111/anae.14670.
[25]	Zhang J, He M, Song Y, et al. Prognostic role of D-dimer level upon admission in patients with traumatic brain injury[J]. Medicine (Baltimore), 2018, 97(31): e11774. DOI: 10.1097/MD.0000000000011774.
[26]	Zhao H, Cai X, Liu N, et al. Thromboelastography as a tool for monitoring blood coagulation dysfunction after adequate fluid resuscitation can predict poor outcomes in patients with septic shock[J]. J Chin Med Assoc, 2020, 83(7): 674-677. DOI: 10.1097/JCMA.0000000000000345.
[27]	Peng Q, Zhao J, Wang P, et al. Expressions of plasma cystatin C, D-dimer and hypersensitive C-reactive protein in patients with intracranial progressive hemorrhagic injury after craniocerebral injury, and their clinical significance[J]. Arq Neuropsiquiatr, 2019, 77(6): 381-386. DOI: 10.1590/0004-282X20190057.
[28]	Fujiwara G, Okada Y, Sakakibara T, et al. The association between D-dimer levels and long-term neurological outcomes of patients with traumatic brain injury: an analysis of a nationwide observational neurotrauma database in Japan[J]. Neurocrit Care, 2022, 36(2): 483-491. DOI: 10.1007/s12028-021-01329-7.
[29]	Karsy M, Kim R, Azab M, et al. Higher admission D-dimer values are associated with an increased risk of nonroutine discharge in neurosurgery patients[J]. Cureus, 2020, 12(7): e9425. DOI: 10.7759/cureus.9425.
[30]	Sheng J, Chen W, Zhuang D, et al. A clinical predictive nomogram for traumatic brain parenchyma hematoma progression[J]. Neurol Ther, 2022, 11(1): 185-203. DOI: 10.1007/s40120-021-00306-8.
[31]	Xu DX, Du WT, Li X, et al. D-dimer/fibrinogen ratio for the prediction of progressive hemorrhagic injury after traumatic brain injury[J]. Clin Chim Acta, 2020, 507: 143-148. DOI: 10.1016/j.cca.2020.04.022.
[32]	Joseph B, Aziz H, Zangbar B, et al. Acquired coagulopathy of traumatic brain injury defined by routine laboratory tests: which laboratory values matter?[J]. J Trauma Acute Care Surg, 2014, 76(1): 121-125. DOI: 10.1097/TA.0b013e3182a9cc95.
[33]	Jha RM, Zusman BE, Puccio AM, et al. Genetic variants associated with intraparenchymal hemorrhage progression after traumatic brain injury[J]. JAMA Netw Open, 2021, 4(7): e2116839. DOI: 10.1001/jamanetworkopen.2021.16839.
[34]	Esnault P, Mathais Q, D'Aranda E, et al. Ability of fibrin monomers to predict progressive hemorrhagic injury in patients with severe traumatic brain injury[J]. Neurocrit Care, 2020, 33(1): 182-195. DOI: 10.1007/s12028-019-00882-6.
[35]	Tréguier Y, Bull-Maurer A, Roingeard P. Apolipoprotein E, a crucial cellular protein in the lifecycle of hepatitis viruses[J]. Int J Mol Sci, 2022, 23(7): 3676. DOI: 10.3390/ijms23073676.
[36]	Hellstrøm T, Andelic N, Holthe Ø, et al. APOE-ε4 is associated with reduced verbal memory performance and higher emotional, cognitive, and everyday executive function symptoms two months after mild traumatic brain injury[J]. Front Neurol, 2022, 13: 735206. DOI: 10.3389/fneur.2022.735206.
[37]	Yousefvand S, Hadjzadeh MA, Keshavarzi Z, et al. Effects of prolactin on movement disorders and APOE, GFAP, and PRL receptor gene expression following intracerebral hemorrhage in rats[J]. Iran J Basic Med Sci, 2021, 24(12): 1709-1716. DOI: 10.22038/IJBMS.2021.58176.12927.
[38]	Wan X, Gan C, You C, et al. Association of APOE ε4 with progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage[J]. J Neurosurg, 2019, Online ahead of print.
[39]	Tzioras M, Davies C, Newman A, et al. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease[J]. Neuropathol Appl Neurobiol, 2019, 45(4): 327-346. DOI: 10.1111/nan.12529.
[40]	Stanczykiewicz B, Gburek J, Rutkowska M, et al. Ovocystatin induced changes in expression of Alzheimer's disease relevant proteins in APP/PS1 transgenic mice[J]. J Clin Med, 2022, 11(9): 2372. DOI: 10.3390/jcm11092372.
[41]	Huang HZ, Qiu M, Lin JZ, et al. Potential effect of tropical fruits Phyllanthus emblica L. for the prevention and management of type 2 diabetic complications: a systematic review of recent advances[J]. Eur J Nutr, 2021, 60(7): 3525-3542. DOI: 10.1007/s00394-020-02471-2.
[42]	Karri J, Cardenas JC, Matijevic N, et al. Early fibrinolysis associated with hemorrhagic progression following traumatic brain injury[J]. Shock, 2017, 48(6): 644-650. DOI: 10.1097/SHK.0000000000000912.
[43]	Allard CB, Scarpelini S, Rhind SG, et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage[J]. J Trauma, 2009, 67(5): 959-967. DOI: 10.1097/TA.0b013e3181ad5d37.
[44]	Wu X, Du Z, Yu J, et al. Activity of factor VII in patients with isolated blunt traumatic brain injury: association with coagulopathy and progressive hemorrhagic injury[J]. J Trauma Acute Care Surg, 2014, 76(1): 114-120. DOI: 10.1097/TA.0b013e3182a8fe48.
[45]	Chen T, Chen S, Wu Y, et al. A predictive model for postoperative progressive haemorrhagic injury in traumatic brain injuries[J]. BMC Neurol, 2022, 22(1): 16. DOI: 10.1186/s12883-021-02541-w.
[46]	Thurman DJ. The epidemiology of traumatic brain injury in children and youths: a review of research since 1990[J]. J Child Neurol, 2016, 31(1): 20-27. DOI: 10.1177/0883073814544363.
[47]	Hu GW, Lang HL, Guo H, et al. A risk score based on admission characteristics to predict progressive hemorrhagic injury from traumatic brain injury in children[J]. Eur J Pediatr, 2017, 176(6): 689-696. DOI: 10.1007/s00431-017-2897-9.
[48]	Yamashita Y, Uozumi R, Hamatani Y, et al. Current status and outcomes of direct oral anticoagulant use in real-world atrial fibrillation patients-Fushimi AF Registry[J]. Circ J, 2017, 81(9): 1278-1285. DOI: 10.1253/circj.CJ-16-1337.
[49]	Koyama H, Yagi K, Hara K, et al. Combination therapy using prothrombin complex concentrate and vitamin K in anticoagulated patients with traumatic intracranial hemorrhage prevents progressive hemorrhagic injury: a historically controlled study[J]. Neurol Med Chir (Tokyo), 2021, 61(1): 47-54. DOI: 10.2176/nmc.oa.2020-0252.
[50]	Steiner T, Poli S, Griebe M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial[J]. Lancet Neurol, 2016, 15(6): 566-573. DOI: 10.1016/S1474-4422(16)00110-1.
[51]	Jehan F, Aziz H, OʼKeeffe T, et al. The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: a propensity matched analysis[J]. J Trauma Acute Care Surg, 2018, 85(1): 18-24. DOI: 10.1097/TA.0000000000001938.
[52]	Munlemvo DM, Tobias JD, Chenault KM, et al. Prothrombin complex concentrates to treat coagulation disturbances: an overview with a focus on use in infants and children[J]. Cardiol Res, 2022, 13(1): 18-26. DOI: 10.14740/cr1342.
[53]	Zeeshan M, Hamidi M, Kulvatunyou N, et al. 3-factor versus 4-factor PCC in coagulopathy of trauma: four is better than three[J]. Shock, 2019, 52(1): 23-28. DOI: 10.1097/SHK.0000000000001240.

Please choose a citation manager

Content to export